Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients

Patients with acute leukemia present with a prolonged and severe course of COVID-19, which is paralleled by high rates of viremia. Low-intensive chemotherapy seems to be more feasible in patients with acute myeloid leukemia and concomitant SARS-CoV-2 infection.

Detalles Bibliográficos
Autores principales: Ghandili, Susanne, Pfefferle, Susanne, Roedl, Kevin, Sonnemann, Piet, Karagiannis, Panagiotis, Boenisch, Olaf, Kluge, Stefan, Schmiedel, Stefan, Ittrich, Harald, Rohde, Holger, Lütgehetmann, Marc, Weisel, Katja, Bokemeyer, Carsten, Wichmann, Dominic, Fiedler, Walter, Jarczak, Dominik, Modemann, Franziska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Exceptional Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724904/
https://www.ncbi.nlm.nih.gov/pubmed/33275765
http://dx.doi.org/10.1182/bloodadvances.2020002543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724904/
https://www.ncbi.nlm.nih.gov/pubmed/33275765
http://dx.doi.org/10.1182/bloodadvances.2020002543

Ejemplares similares